Nova In Silico

novainsilico.com · Vienna, Austria

Nova In Silico is a biotechnology and computational modeling company that develops in silico (computer-based) models to support drug discovery, toxicology assessment, and biological research. It provides simulation tools and services that help pharmaceutical, biotech, and research organizations predict biological responses and optimize R&D decisions. The company generates revenue through software licensing, modeling projects, and related scientific consulting services.

Revenue
<$10M
Employees
1 - 50
Founded
2018
Headquarters
Vienna, Austria

Nova In Silico customers on Arbolus

Total customers 9 6 current · 3 former
Reviews growth 5 new reviews since Feb 2026

Customers who reviewed Nova In Silico

Seniority of Nova In Silico customers

Most people who reviewed Nova In Silico hold Director roles (56%), followed by C-Suite (33%) and Manager (11%).

  • Director 56%
  • C-Suite 33%
  • Manager 11%

Customers sample

Strategy Leader Director NPS 10 Will renew
Other Leader Manager NPS 10
Revenue Partner Director NPS 8

Employer names and spend open once the report publishes.

What 9 Arbolus experts think of Nova In Silico

Overall sentiment: Positive

NPS scores cluster in the 8–10 range, with 44% Promoters (NPS 10) and 56% Passives (NPS 7–8). Explicit renewal intent is high among those with significant spend, while lower spenders are less committed or in early-stage pilots. Implementation stages spread across less than one year to more than a year, with early-stage projects expressing cautious optimism. Key quantitative themes are enthusiastic satisfaction among decision-makers with options for growth as pilot stages mature.

Tell us when the Nova In Silico report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Sentiment

33 Net Promoter Score, from 9 scored reviews
  • Promoters 3
  • Passives 6
  • Detractors 0

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 75%
  • Will renew 3
  • Undecided 1
  • Not renewing 0

Plan to renew, by seniority

  • C-Suite 50% 2 answers
  • Director 100% 2 answers
  • 9.3/10 Average score from customers who will renew
  • 8/10 Average score from undecided customers

For people who use Nova In Silico

Do you use Nova In Silico at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 9 customers of Nova In Silico have already contributed

Takes a few minutes. Your identity stays anonymous.